Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systemically administered kainic acid
- 1 March 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 32 (3) , 241
- https://doi.org/10.1212/wnl.32.3.241
Abstract
Pretreatment of rats with homotaurine (3 aminopropanesulfonic acid; 3APS), a synthetic γ-aminobutyric acid (GABA) analog, protected from the convulsant and cytotoxic action of systemically injected kainic acid (KA). Wet dog shaking (WDS) behavior was significantly reduced. Taurine, an inhibitory non-GABA-mimetic amino acid, and muscimol (another direct GABA-agonist) reduced the number of seizures and lesions in the brain but were less effective than homotaurine. Progabide (a GABA-agonist) did not modify kainic acid effects. The neurotoxicity of kainic acid could have been due to repetitive convulsive activity. Activation of GABA-mediated inhibition is an effective, but not the determinant means of preventing KA-induced abnormalities.This publication has 4 references indexed in Scilit:
- Protection by 4-amino-hex-5-enoic acid (?-vinyl GABA) and hypobaric hypoxia against kainic acid neurotoxicityPsychopharmacology, 1979
- Kainic acid lesions of the striatum in rats mimic the spontaneous motor abnormalities of Huntington's diseaseNeuropharmacology, 1979
- Interactions of thyrotropin releasing hormone and morphine sulfate in rodentsLife Sciences, 1977
- Chemical stimulants of shaking behaviourJournal of Pharmacy and Pharmacology, 1976